Abo Bibliothek: Guest
Digitales Portal Digitale Bibliothek eBooks Zeitschriften Referenzen und Berichte Forschungssammlungen
Critical Reviews™ in Eukaryotic Gene Expression
Impact-faktor: 1.841 5-jähriger Impact-Faktor: 1.927 SJR: 0.649 SNIP: 0.516 CiteScore™: 1.96

ISSN Druckformat: 1045-4403
ISSN Online: 2162-6502

Critical Reviews™ in Eukaryotic Gene Expression

DOI: 10.1615/CritRevEukaryotGeneExpr.2017019085
pages 151-161

Mini-Review on Cachexia-Related miRNA

Fábio Sousa Nunes
Department of Physiology and Cardiothoracic Surgery, Faculty of Medicine, Porto, Portugal
Daniel Moreira-Gonçalves
Department of Physiology and Cardiothoracic Surgery, Faculty of Medicine, Porto, Portugal
Tiago Henriques-Coelho
Department of Pediatrics, Faculty of Medicine, Porto, Portugal

ABSTRAKT

Cachexia, or muscle wasting, is a complex metabolic syndrome associated with an underlying illness and characterized by loss of muscle mass. It is a rather prevalent condition, with impacts on patient survival, response to treatment, and quality of life. Treatment options are sparse because of cachexia's multifactorial pathogenesis. Recently, attention has focused on microRNAs (miRNAs) as potential therapeutic targets of several diseases. miRNAs are small, 18- to 25-base-long constructs that regulate gene expression on a post-transcriptional level, selectively activating or repressing elements of specific signaling pathways. In this review, we investigated whether miRNAs play any role in cachexia's biochemical pathways and if miRNA targeting has any significant impact on preclinical models of cachexia.


Articles with similar content:

Prognostic and Predictive Role of Raf Kinase Inhibitor Protein (RKIP) Within the RAS/ MAP Signaling Pathway in Colorectal Cancer
Forum on Immunopathological Diseases and Therapeutics, Vol.2, 2011, issue 2
A. Lugli, P. Minoo, I. Zlobec
miRNA: A Diagnostic and Therapeutic Tool for Pancreatic Cancer
Critical Reviews™ in Eukaryotic Gene Expression, Vol.27, 2017, issue 3
Muhammad Imran Qadir, Arooj Faheem
Therapeutic YY1 Inhibitors in Cancer: ALL in ONE
Critical Reviews™ in Oncogenesis, Vol.22, 2017, issue 1-2
Benjamin Bonavida
From Targets to Targeted Therapies in Hepatocellular Carcinoma
Forum on Immunopathological Diseases and Therapeutics, Vol.5, 2014, issue 3-4
Melchiorre Cervello, Antonella Cusimano, Maria Rita Emma, Antonina Azzolina, Giuseppa Augello, James A. McCubrey, Daniele Balasus
Scientific Documentation of the Relationship of Vitamin D Deficiency and the Development of Cancer
Journal of Environmental Pathology, Toxicology and Oncology, Vol.28, 2009, issue 2
William B. Long III, Shelley S. Mason, Jerry D. Giesy, Richard Edlich, Allyson L. Fisher, Margot E. Chase, K. Dean Gubler, Marni L. Foley